サンプル依頼リスト カート
  • English
  • Korean
表紙：瘢痕治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1331395

瘢痕治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年

Scar Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Scar Product, By End User, Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 112 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

瘢痕治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 112 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

瘢痕治療市場は、手術件数の増加、瘢痕管理に対する意識の高まり、新たな治療オプションの開拓、可処分所得の増加、高齢者人口の増加などにより、予測期間中に目覚ましい成長が見込まれます。

外科手術数の増加

外科手術数の増加は、世界の瘢痕治療市場の主要促進要因の一つです。外科手術は瘢痕を残すことが多く、そのため瘢痕治療に対する需要は、世界中で行われる手術件数の増加に伴って増加しています。

外科手術がより一般的で複雑なものになるにつれて、効果的な瘢痕管理の必要性も高まっています。患者は手術後の瘢痕の見た目を気にするようになっており、ヘルスケア専門家は術後ケアの重要な側面として瘢痕管理の重要性を強調しています。

さらに、低侵襲手術の台頭により、瘢痕管理の重要性はさらに高まっています。低侵襲手術は瘢痕を最小限に抑えるようにデザインされていますが、最高の技術をもってしても瘢痕が残ることがあります。瘢痕治療は、瘢痕の見た目を最小限に抑え、手術結果に対する患者の満足度を向上させるのに役立ちます。

さらに、美容整形や皮膚科治療などの美容施術の増加も、瘢痕治療の需要を押し上げています。これらの手術を受ける患者は、瘢痕を気にすることが多く、瘢痕をできるだけ小さく目立たないようにしたいと考えています。

治療と美容の両面で外科手術の件数が増加していることが、世界の瘢痕治療市場の成長を促進しています。

瘢痕管理に対する意識の高まり

瘢痕管理に対する意識の高まりが、世界の瘢痕治療市場の成長を後押ししています。瘢痕は人の身体的、心理的な幸福に大きな影響を与える可能性があるため、瘢痕管理はヘルスケアの重要な側面となっています。瘢痕治療は、瘢痕の外観、質感、柔軟性を改善すると同時に、かゆみや痛みといった瘢痕に関連する症状を最小限に抑えることを目的としています。

皮膚損傷、火傷、手術、外傷の増加により、瘢痕治療を求める人の数が増加しています。さらに、非侵襲的で低侵襲の瘢痕治療オプションに対する需要の高まりと瘢痕治療技術の進歩が、市場の成長をさらに促進しています。

さらに、ヘルスケア専門家や患者の間で瘢痕管理の潜在的な利点に対する認識が高まっていることが、早期介入や治療成績の向上につながっています。瘢痕管理は今や手術後や創傷治療の不可欠な一部となっており、この動向は今後も続くと予想されます。

さらに、局所クリーム、シリコンシート、レーザー治療、外科的処置など、幅広い瘢痕治療製品やサービスが利用可能なことも、市場の成長を後押ししています。瘢痕治療製品やサービスの採用が増加していることから、世界の瘢痕治療市場は今後も成長を続けると予想されます。

利用可能なカスタマイズ

TechSci Research社は、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 瘢痕治療の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別（局所製品、レーザー製品、注射剤、その他）
    • 瘢痕用製品別（萎縮性瘢痕、肥厚性・ケロイド性瘢痕、拘縮性瘢痕、妊娠線）
    • エンドユーザー別（病院、外来診療センター、その他）
    • 地域別
    • 企業別（2022年）
  • 製品マップ
    • 製品別
    • 瘢痕タイプ別
    • エンドユーザー別
    • 地域別

第6章 北米の瘢痕治療市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 瘢痕タイプ別
    • エンドユーザー別
    • 国別
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の瘢痕治療市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 瘢痕タイプ別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の瘢痕治療市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 瘢痕タイプ別
    • エンドユーザー別
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の瘢痕治療市場の展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 瘢痕タイプ別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの瘢痕治療市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 瘢痕タイプ別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品発表

第13章 瘢痕治療の世界市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Key Personnel
  • SWOT Analysis
    • Smith & Nephew PLC
    • Lumenis Ltd.
    • Merz Pharmaceuticals, LLC
    • Sonoma Pharmaceuticals, Inc.
    • Cynosure, LLC
    • CCA Industries, Inc.
    • Newmedical Technology Inc.
    • Molnlycke Health Care AB

第16章 戦略的提言

目次
Product Code: 15362

Scar Treatment Market is expected to witness impressive growth during the forecast period, thanks to the increasing number of surgical procedures, rising awareness about scar management, the development of new treatment options, increasing disposable income, and the growing geriatric population.

Scars are a common result of injury or surgery and can have both physical and emotional impacts on individuals. Fortunately, there are several treatment options available to reduce the appearance of scars.

One of the key factors driving the growth of the scar treatment market is the increasing number of surgical procedures performed each year. As more individuals undergo surgical procedures, the demand for scar treatments increases. The most common surgical procedures that result in scarring include cosmetic surgeries, such as breast augmentation and tummy tucks, and orthopedic surgeries, such as joint replacements.

Another factor driving the growth of the scar treatment market is the rising awareness about scar management. With the growing availability of information online, more individuals are becoming aware of the different types of scar treatments available. Additionally, healthcare providers are increasingly educating patients on the importance of scar management and the different treatment options available.

The growing geriatric population is also driving the growth of the scar treatment market. As individuals age, their skin becomes thinner and less elastic, making them more susceptible to scarring. The growing geriatric population is also more likely to undergo surgical procedures in the coming years, further increasing the demand for scar treatments.

Additionally, the development of new scar treatment options is another factor driving the growth of the scar treatment market. Recent advancements in technology have led to the development of new treatment options, such as laser therapy and injectable products. These new treatment options offer patients more effective and less invasive alternatives to traditional scar treatments.

The scar treatment market has seen several notable product launches over the last three years, including Stratpharma's StrataXRT, Smith & Nephew's PICO 7Y Single-use Negative Pressure Wound Therapy System, Avita Medical's RECELL, Lumenis' M22 IPL, and RenovaCare's SkinGun.

In 2020, Swiss-based Stratpharma launched StrataXRT, a medical-grade silicone gel for the treatment of radiation-induced dermatitis and burns. The product is designed to prevent and treat radiation-induced skin damage and improve skin hydration and elasticity. It has received FDA clearance and is available in the United States.

In 2019, Smith & Nephew launched the PICO 7Y Single-use Negative Pressure Wound Therapy System. The product is designed to manage surgical wounds and prevent scars. The system uses negative pressure to remove fluid and reduce swelling, allowing the wound to heal more quickly and reducing the risk of scarring.

In 2018, Avita Medical launched RECELL, a product designed to promote healing and reduce scarring in patients with burns. The product uses a small sample of the patient's skin to create a spray-on solution that can be applied to the wound. The product has been approved by the FDA and is available in the United States.

The growth of the global scar treatment market will be impeded by the location of the scar, type of scar, age of the scar, patient health, and cost of treatment. The age of a scar can impact the effectiveness of treatment. Scars that are less than a year old may respond well to topical treatments such as silicone sheets and gels. However, scars that are several years old may require more invasive treatments such as laser therapy or surgery. The age of a scar can also impact the type of treatment recommended, as some treatments may not be appropriate for older scars.

The location of a scar can greatly impact the effectiveness of treatment. Scars in visible areas, such as the face, can cause emotional distress and impact a person's self-esteem. Additionally, scars in areas that are constantly in motion, such as the hands, may not respond well to certain treatments. Scar location can also impact the type of treatment recommended, as some treatments may not be appropriate for certain areas of the body.

While scar treatment options have existed for many years, recent developments in the field have led to more effective and innovative treatment options. Micro-needling, PRP therapy, laser therapy, scar revision surgery, and topical treatments are just a few examples of the advancements in scar treatment. Platelet-rich plasma (PRP) therapy is a treatment that uses a patient's blood to promote healing. The patient's blood is processed to extract a concentration of platelets, which are then injected into the scar tissue. Platelets contain growth factors that can promote collagen production and stimulate healing. PRP therapy is often used to treat scars that have not responded well to other treatments.

Micro-needling is a relatively new scar treatment that involves using tiny needles to create micro-injuries in the skin. This process stimulates the body's natural healing response and promotes collagen production, which can improve the appearance of scars. Micro-needling can be used to treat a variety of scars, including acne scars and surgical scars. This treatment is minimally invasive and has minimal downtime.

Topical treatments, such as silicone sheets and gels, have been used for scar treatment for many years. Recent developments in topical treatments have led to more effective and innovative products. For example, some topical treatments now contain growth factors or other compounds that can promote collagen production and accelerate healing. Additionally, some topical treatments now come in spray or foam form, making them easier to apply and more convenient for patients.

Increasing Number of Surgical Procedures

The increasing number of surgical procedures is one of the key drivers of the global scar treatment market. Surgical procedures often result in scarring, and the demand for scar treatment is therefore increasing in tandem with the rising number of surgeries being performed worldwide.

As surgical procedures become more common and complex, the need for effective scar management also grows. Patients are increasingly concerned about the appearance of scars after surgery, and healthcare professionals are emphasizing the importance of scar management as a crucial aspect of post-operative care.

Moreover, with the rise of minimally invasive surgeries, scar management is becoming even more important. Minimally invasive procedures are designed to minimize scarring, but even with the best techniques, some scarring may still occur. Scar treatment can help to minimize the appearance of scars and improve patient satisfaction with the outcome of their surgery.

Furthermore, the increasing number of aesthetic procedures, such as cosmetic surgery and dermatological treatments, is also driving the demand for scar treatment. Patients who undergo these procedures are often concerned about scarring and want to ensure that their scars are as minimal and inconspicuous as possible.

The increasing number of surgical procedures, both therapeutic and cosmetic, is driving the growth of the global scar treatment market.

Rising Awareness About Scar Management

The rising awareness about scar management is indeed driving the growth of the global scar treatment market. Scar management has become an important aspect of healthcare as scars can have a significant impact on a person's physical and psychological well-being. Scar treatment aims to improve the appearance, texture, and flexibility of scars while also minimizing their associated symptoms, such as itching and pain.

The increasing prevalence of skin injuries, burns, surgeries, and trauma has led to a rise in the number of people seeking scar treatment. Moreover, the growing demand for non-invasive and minimally invasive scar treatment options, coupled with advancements in scar treatment technologies, is further fueling the market growth.

Additionally, the rising awareness about the potential benefits of scar management among healthcare professionals and patients is leading to early intervention and better treatment outcomes. Scar management is now an integral part of post-surgery and wound care, and this trend is expected to continue in the coming years.

Furthermore, the availability of a wide range of scar treatment products and services, including topical creams, silicone sheets, laser therapy, and surgical procedures, is driving market growth. With the increasing adoption of scar treatment products and services, the global scar treatment market is expected to continue growing in the years ahead.

Market Segmentation

The global scar treatment market can be segmented by product, scar product, end user, and region. Based on product, the market can be divided into topical products, laser products, injectables, and others. Based on scar products, the market is divided into atrophic scars, hypertrophic & keloid scars, contracture scars, and stretch marks. Based on end-user, the market is divided into hospitals & clinics, ambulatory care centers, and others. Regionally, the Scar treatment market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Smith & Nephew PLC, Lumenis Ltd., Merz Pharmaceuticals, LLC, Sonoma Pharmaceuticals, Inc., Cynosure, LLC, CCA Industries, Inc., Newmedical Technology Inc., and Molnlycke Health Care AB are some of the leading players operating in the global scar treatment market.

Report Scope:

In this report, the global scar treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Global Scar Treatment Market, By Product:

  • Topical Products
  • Laser Products
  • Injectables
  • Others

Global Scar Treatment Market, By Scar Product:

  • Atrophic Scars
  • Hypertrophic & Keloid Scars
  • Contracture Scars
  • Stretch Marks

Global Scar Treatment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Scar Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Scar Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Topical Products, Laser Products, Injectables, Others)
    • 5.2.2. By Scar Product (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, Stretch Marks)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Product
    • 5.3.2. By Scar Type
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Scar Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Scar Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Scar Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Scar Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Scar Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Scar Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Scar Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Scar Type
        • 6.3.3.2.3. By End User

7. Europe Scar Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Scar Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Scar Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Scar Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Scar Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Scar Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Scar Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Scar Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Scar Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Scar Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Scar Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Scar Type
        • 7.3.5.2.3. By End User

8. Asia-Pacific Scar Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Scar Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Scar Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Scar Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Scar Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Scar Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Scar Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Scar Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Scar Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Scar Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Scar Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Scar Type
        • 8.3.5.2.3. By End User

9. South America Scar Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Scar Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Scar Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Scar Type
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Scar Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Scar Type
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Scar Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Scar Type
        • 9.3.3.2.3. By End User

10. Middle East and Africa Scar Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Scar Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Scar Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Scar Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Scar Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Scar Type
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Scar Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Scar Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Scar Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Smith & Nephew PLC
    • 15.5.2. Lumenis Ltd.
    • 15.5.3. Merz Pharmaceuticals, LLC
    • 15.5.4. Sonoma Pharmaceuticals, Inc.
    • 15.5.5. Cynosure, LLC
    • 15.5.6. CCA Industries, Inc.
    • 15.5.7. Newmedical Technology Inc.
    • 15.5.8. Molnlycke Health Care AB

16. Strategic Recommendations